World's Best Scientists 2026 revealed!
Chiara Riganti

Chiara Riganti

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
15560
World Ranking
8672
National Ranking
236

Chiara Riganti publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Chiara Riganti sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 335 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Chiara Riganti D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Chiara Riganti sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 66 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Chiara Riganti is affiliated with the University of Turin in Italy and has a significant research portfolio primarily in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work spans molecular biology, oncology, pulmonary and respiratory medicine, and cancer research, with strong intersections in materials chemistry.

The scientist's main areas of study include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Subfields of particular focus are:

  • Molecular Biology
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Materials Chemistry

Chiara Riganti's research topics encompass drug transport and resistance mechanisms, cancer biology, hypoxia, metabolism, nanoparticle-based drug delivery, lung diseases related to occupation and environment, cancer therapeutics, crystallization and solubility studies, and X-ray diffraction in crystallography.

  • Drug Transport and Resistance Mechanisms
  • Cancer, Hypoxia, and Metabolism
  • Nanoparticle-Based Drug Delivery
  • Occupational and environmental lung diseases
  • Cancer therapeutics and mechanisms
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography

Among the recent publications associated with Chiara Riganti are:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, 2020, Journal for ImmunoTherapy of Cancer
  • Hypoxia as a driver of resistance to immunotherapy, 2021, Drug Resistance Updates
  • Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons, 2021, Journal of Experimental & Clinical Cancer Research
  • Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells, 2020, Biomolecules
  • Impact of cancer metabolism on therapy resistance - Clinical implications, 2021, Drug Resistance Updates

Frequent co-authors include:

  • Joanna Kopecka
  • Iris C. Salaroglio
  • Martina Godel
  • Dimas Carolina Belisario
  • Marialessandra Contino

Chiara Riganti has published frequently in several venues such as:

  • The Cambridge Structural Database
  • Journal of Experimental & Clinical Cancer Research
  • International Journal of Molecular Sciences
  • Journal of Medicinal Chemistry
  • Cancers

Best Publications

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate.

    Chiara Riganti;Elena Gazzano;Manuela Polimeni;Elisabetta Aldieri

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.

    Chiara Riganti;Erica Miraglia;Daniele Viarisio;Costanzo Costamagna

  • Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

    Marta Coscia;Elena Quaglino;Manuela Iezzi;Claudia Curcio

  • Diphenyleneiodonium Inhibits the Cell Redox Metabolism and Induces Oxidative Stress

    Chiara Riganti;Elena Gazzano;Manuela Polimeni;Costanzo Costamagna

  • Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific

    Elisabetta Aldieri;Chiara Riganti;Manuela Polimeni;Elena Gazzano

  • Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation

    Elisabetta Aldieri;Daniela Atragene;Loredana Bergandi;Chiara Riganti

  • HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast

    Sophie Michelle Doublier;Dimas Carolina Belisario;Manuela Polimeni;Laura Annaratone

  • Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.

    Joanna Kopecka;Patrick Trouillas;Ana Čipak Gašparović;Elena Gazzano

  • PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy

    Iris Chiara Salaroglio;Elisa Panada;Elisa Panada;Enrico Moiso;Ilaria Buondonno

  • Hypoxia as a driver of resistance to immunotherapy

    Joanna Kopecka;Iris C. Salaroglio;Elizabeth Perez-Ruiz;Ana Bela Sarmento-Ribeiro

  • Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression.

    Chiara Riganti;Sophie Michelle Doublier;D Viarisio;Erica Miraglia

  • ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer

    Iris C. Salaroglio;Eleonora Mungo;Elena Gazzano;Joanna Kopecka

  • Fluoride effects: the two faces of janus.

    E. Gazzano;L. Bergandi;C. Riganti;E. Aldieri

  • Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest

    Michela Capello;Sammy Ferri-Borgogno;Sammy Ferri-Borgogno;Chiara Riganti;Michelle Samuel Chattaragada

  • Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.

    Chiara Riganti;Claudia Voena;Joanna Kopecka;Paola Antonia Corsetto

  • Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis

    Moitza Principe;Simone Borgoni;Mariafrancesca Cascione;Michelle Samuel Chattaragada

  • Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition

    Giada Gelsomino;Paola A Corsetto;Ivana Campia;Gigliola Montorfano

Frequent Co-Authors

Dario Ghigo
Dario Ghigo University of Turin
Amalia Bosia
Amalia Bosia University of Turin
Massimo Massaia
Massimo Massaia University of Turin
Mario Boccadoro
Mario Boccadoro University of Turin
Francesco Novelli
Francesco Novelli University of Turin
Michele Lanotte
Michele Lanotte University of Turin
Salvatore Sortino
Salvatore Sortino University of Catania
Silvia Novello
Silvia Novello University of Turin
Bice Fubini
Bice Fubini University of Turin
Silvia Deaglio
Silvia Deaglio University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to a wide range of healthcare and science careers. Many students complement their studies by pursuing flexible online degrees and certificates tailored to specialized roles in healthcare and nutrition.

For those interested in mental health, the shortest online pmhnp certificate programs provide an accelerated pathway to become a Psychiatric Mental Health Nurse Practitioner. Alternatively, nurses seeking advancement might consider a 1 year post master's fnp online program, which enables quick completion for a Family Nurse Practitioner certification.

Nutrition-focused graduates can pursue a dietitian degree online to gain credentials in dietetics while maintaining flexibility. Registered Nurses may also benefit from rn to bsn online no clinicals options, making it easier to advance their education with fewer on-site requirements.

Whether your interests are in laboratory science, patient care, or nutrition, these online pathways support flexible learning and diverse career outcomes after a foundation in Biology or Biochemistry.

Best Scientists Citing Chiara Riganti

Trending Scientists

Recently Published Articles